Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations

Oncology Reports

Volumn 26, Issue 2, 2011, Pages 447-453

  Wybieralska, Ewa ^a   Szpak, Katarzyna ^a   Górecki, Andrzej ^a   Bonarek, Piotr ^a   Miȩkus, Katarzyna ^b   Drukała, Justyna ^a   Majka, Marcin ^b   Reiss, Krzysztof ^c   Madeja, Zbigniew ^a   Czyz, Jarosław ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Connexin; Fenofibrate; Invasion; Motility; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; CONNEXIN 43; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CONTACT; CELL MEMBRANE; CELL MOTILITY; CELL STRAIN DU 145; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GAP JUNCTION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; METASTASIS POTENTIAL; MIGRATION INHIBITION; MONOLAYER CULTURE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TIME LAPSE IMAGING; VISCOSITY;

CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CONNEXIN 43; FENOFIBRATE; GAP JUNCTIONS; HUMANS; MALE; NEOPLASM INVASIVENESS; PPAR ALPHA; PROSTATIC NEOPLASMS;

EID: 79958237900     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1321     Document Type: Article

References (37)

1. Friedl P and Wolf K: Plasticity of cell migration: a multiscale tuning model. J Exp Med 207: 11-19, 2010.
2. Yamasaki H, Krutovskikh V, Mesnil M, et al: Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C R Acad Sci III 322: 151-159, 1999.
3. Laird DW: Life cycle of connexins in health and disease. Biochem J 394: 527-543, 2006.
4. Trosko JE: Gap junctional intercellular communication as a biological 'Rosetta stone' in understanding, in a systems biological manner, stem cell behavior, mechanisms of epigenetic toxicology, chemoprevention and chemotherapy. J Membr Biol 218: 93-100, 2007.
5. Fujimoto E, Satoh H, Negishi E, et al: Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2. Mol Carcinog 40: 135-142, 2004. (Pubitemid 38924840)
6. Lin JH, Takano T, Cotrina ML, et al: Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 22: 4302-4311, 2002. (Pubitemid 37465645)
7. Pollmann MA, Shao Q, Laird DW and Sandig M: Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 7: R522-R534, 2005.
8. Cronier L, Crespin S, Strale PO, Defamie N and Mesnil M: Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 11: 323-338, 2009.
9. Chinetti G, Fruchart JC and Staels B: Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49: 497-505, 2000.
10. Jiao HL and Zhao BL: Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms. Toxicol Appl Pharmacol 185: 172-179, 2002.
11. Scatena R, Bottoni P, Vincenzoni F, et al: Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Chem Res Toxicol 16: 1440-1447, 2003. (Pubitemid 37464465)
12. Grabacka M, Placha W, Plonka PM, et al: Inhibition of melanoma metastases by fenofibrate. Arch Dermatol Res 296: 54-58, 2004.
13. Grabacka M, Plonka PM, Urbanska K and Reiss K: Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res 12: 3028-3036, 2006. (Pubitemid 43837347)
14. Panigrahy D, Kaipainen A, Huang S, et al: PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. Proc Natl Acad Sci USA 105: 985-990, 2008. (Pubitemid 351282068)
15. Thuillier P, Anchiraico GJ, Nickel KP, et al: Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion. Mol Carcinog 29: 134-142, 2000.
16. Saidi SA, Holland CM, Charnock-Jones DS and Smith SK: In vitro and in vivo effects of the PPARalpha agonists fenofibrate and retinoic acid in endometrial cancer. Mol Cancer 5: 13, 2006.
17. Grabacka M and Reis K: Effects on cellular metabolism and inflammation. PPAR Pes 2008: 930705, 2008.
18. Drukala J, Urbanska K, Wilk A, et al: ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha-mediated inhibition of glioma cell motility in vitro. Mol Cancer 9: 159, 2010.
19. Gamerdinger M, Clement AB and Behl C: Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production. Mol Pharmacol 72: 141-151, 2007. (Pubitemid 46998533)
20. Scatena R, Martorana GE, Bottoni P and Giardina B: Mitochondrial dysfunction by synthetic ligands of peroxisome proliferator activated receptors (PPARs). IUBMB Life 56: 477-482, 2004. (Pubitemid 39576897)
21. Scatena R, Bottoni P and Giardina B: Mitochondria, PPARs, and cancer: Is receptor-independent action of PPAR agonists a key? PPAR Res 2008: 256251, 2008.
22. Miekus K, Czernik M, Sroka J, Czyz J and Madeja Z: Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Biol Cell 97: 893-903, 2005. (Pubitemid 41819307)
23. Czyz J: The stage-specific function of gap junctions during tumourigenesis. Cell Mol Biol Lett 13: 92-102, 2008.
24. Sroka J, Czyz J, Wojewoda M and Madeja Z: The inhibitory effect of diphenyltin on gap junctional intercellular communication in HEK-293 cells is reduced by thioredoxin reductase 1. Toxicol Lett 183: 45-51, 2008.
25. Sroka J, Antosik A, Czyz J, et al: Overexpression of thioredoxin reductase 1 inhibits migration of HEK-293 cells. Biol Cell 99: 677-687, 2007. (Pubitemid 350201918)
26. Madeja Z, Miekus K, Sroka J, Djamgoz MB and Korohoda W: Homotypic cell-cell contacts stimulate the motile activity of rat prostate cancer cells. BJU Int 88: 776-786, 2001.
27. Madeja Z, Szymkiewicz I, Zaczek A, et al: Contact-activated migration of melanoma B16 and sarcoma XC cells. Biochem Cell Biol 79: 425-440, 2001. (Pubitemid 32744978)
28. Butkerait P, Zheng Y, Hallak H, et al: Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem 270: 18691-18699, 1995.
29. Miekus K, Jarocha D, Trzyna E and Majka M: Pole of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines. Folia Histochem Cytobiol 48: 104-111, 2010.
30. Czyz J, Guan K, Zeng Q and Wobus AM: Loss of beta1 integrin function results in upregulation of connexin expression in embryonic stem cell-derived cardiomyocytes. Int J Dev Biol 49: 33-41, 2005. (Pubitemid 40516366)
31. Daniel-Wojcik A, Misztal K, Bechyne I, et al: Cell motility affects the intensity of gap junctional coupling in prostate carcinoma and melanoma cell populations. Int J Oncol 33: 309-315, 2008.
32. Leesnitzer LM, Parks DJ, Bledsoe RK, et al: Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41: 6640-6650, 2002. (Pubitemid 34547354)
33. Ghosh PK, Vasanji A, Murugesan G, et al: Membrane microviscosity regulates endothelial cell motility. Nat Cell Biol 4: 894-900, 2002. (Pubitemid 35331365)
34. Urbanska K, Pannizzo P, Grabacka M, et al: Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer 123: 1015-1024, 2008.
35. Dellavalle RP, Nicholas MK and Schilling LM: Melanoma chemoprevention: a role for statins or fibrates? Am J Ther 10: 203-210, 2003.
36. Czernik M, Sroka J, Madeja Z and Czyz J: Apigenin inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations. Cell Mol Biol Lett 13: 327-338, 2008.
37. Miekus K and Madeja Z: Genistein inhibits the contact-stimulated migration of prostate cancer cells. Cell Mol Biol Lett 12: 348-361, 2007.